1. Baldessarini RJ (2001). Drugs and the treatment of psychiatric disorders: depression and anxiety disorders. In: Hardman JG, Limbird LE, Gilman AG (eds). Goodman & Gilman's The Pharmacological Basis of Therapeutics, 10th edn. McGraw-Hill: New York. pp 447–483.
2. Barbey JT, Roose SP (1998). SSRI safety in overdose. J Clin Psychiatry 59(Suppl 15): 42–48.
3. Baumann P, Gaillard J-M, Jonzier-Perey M, Gerber C, Bouras C (1984). Evaluation of the levels of free and total amitriptyline and metabolites in the plasma and brain of the rat after long-term administration of doses used in receptor studies. Psychopharmacology 84: 489–495.
4. Baumann P, Gaillard J-M, Perey M, Justafré J-C, Le P (1983). Relationships between brain concentrations of desipramine and paradoxical sleep inhibition in the rat. J Neural Transm 56: 105–116.
5. Besret L, Debruyne D, Rioux P, Bonvalot T, Moulin M, Zarifian E et al (1996). A comprehensive investigation of plasma and brain regional pharmacokinetics of imipramine and its metabolites during and after chronic administration in the rat. J Pharm Sci 85: 291–295.